miR-216b Inhibits Cervical Cancer Cells Autophagy by Regulating Beclin-1 Expression
-
摘要:目的
研究miR-216b影响宫颈癌HeLa细胞自噬的作用机制。
方法转染miR-216b及应用其抑制剂后,利用GFP-LC3 shRNA转染等方法检测HeLa细胞的自噬水平,Western blot检测自噬相关基因Beclin-1和LC3-Ⅱ的表达变化。
结果HeLa细胞转染miR-216b后,HeLa细胞中自噬相关基因Beclin-1受到抑制,LC3-Ⅱ的表达增加,细胞自噬受抑,而抑制miR-216b的表达,自噬水平升高。进一步研究发现,miR-216b能够通过靶结合Beclin-1 3’UTR抑制Beclin-1表达从而抑制细胞自噬的发生。
结论miR-216b能够抑制宫颈癌HeLa细胞发生自噬,为宫颈癌的临床治疗提供了的理论基础。
Abstract:ObjectiveTo investigate the effect of miR-216b on autophagy in cervical cancer HeLa cells.
MethodsAfter the transfection of miR-216b and the application of their inhibitors,we used GFP-LC3 shRNA transfection to test the autophagy levels of HeLa cells and Western blot to test the expression changes of autophagy-related genes Beclin-1 and LC3-Ⅱ.
ResultsAfter transfected with miR-216b,autophagy related gene Beclin-1 was inhibited in HeLa cells,the expression of LC3-Ⅱ was increased,and autophagy was inhibited; however,the level of autophagy was increased when the expression of miR-216b was inhibited. Further,miR-216b can inhibit the occurrence of autophagy by inhibiting the expression of Beclin-1 by targeting Beclin-1 3’UTR.
ConclusionmiR-216b could inhibit HeLa cells autophagy,which provides a theoretical basis for the clinical treatment of cervical cancer.
-
Key words:
- miR-216b /
- Cervical cancer /
- Autophagy /
- Beclin-1
-
-
-
[1] 魏矿荣, 陈万青, 张思维, 等. 中国部分肿瘤登记地区2003-2007 年子宫体癌的流行概况[J]. 中华妇产科杂志, 2012, 47(6): 445-51. [Wei KR, Chen WQ, Zhang SW, et al. Epidemiology of uterine corpus cancer in some cancer registering areas of China from 2003-2007[J]. Zhonghua Fu Chan Ke Za Zhi, 2012, 47(6): 445-51.] [1] 魏矿荣,陈万青,张思维,等. 中国部分肿瘤登记地区2003-2007年子宫体癌的流行概况[J]. 中华妇产科杂志,2012,47(6): 445-51. Wei KR,Chen WQ,Zhang SW,et al. Epidemiology of uterine corpus cancer in some cancer registering areas of China from 2003-2007[J]. Zhonghua Fu Chan Ke Za Zhi,2012,47(6): 445-51.
[2] He Y, Lin J, Ding Y, et al. A systematic study on dysregulated microRNAs in cervical cancer development[J]. Int J Cancer, 2016, 138(6): 1312-27. [2] He Y,Lin J,Ding Y,et al. A systematic study on dysregulated microRNAs in cervical cancer development[J]. Int J Cancer,2016,138(6): 1312-27. doi: 10.1002/ijc.29618
[3] Tilki D, Burger M, Dalbagni G,et al. Urine markers for detection and surveillance of non-muscle-invasive bladder cancer[J]. Eur Urol,2011,60(3): 484-92. doi: 10.1016/j.eururo.2011.05.053
[3] Tilki D, Burger M, Dalbagni G, et al. Urine markers for detection and surveillance of non-muscle-invasive bladder cancer[J]. Eur Urol, 2011, 60(3): 484-92. [4] Cortez MA, Bueso-Ramos C, Ferdin J,et al. MicroRNAs in body fluids-the mix of hormones and biomarkers[J]. Nat Rev Clin Oncol,2011,8(8): 467-77. doi: 10.1038/nrclinonc.2011.76
[4] Cortez MA, Bueso-Ramos C, Ferdin J, et al. MicroRNAs in body fluids-the mix of hormones and biomarkers[J]. Nat Rev Clin Oncol, 2011, 8(8): 467-77. [5] Matullo G,Naccarati A,Pardini B. MicroRNA expression profiling in bladder cancer: the challenge of next-generation sequencing in tissues and biofluids[J]. Int J Cancer,2016,138(10): 2334-45. doi: 10.1002/ijc.v138.10
[5] Matullo G, Naccarati A, Pardini B. MicroRNA expression profiling in bladder cancer: the challenge of next-generation sequencing in tissues and biofluids[J]. Int J Cancer, 2016, 138(10): 2334-45. [6] Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues[J]. Cell, 2011, 147(4): 728-41. [6] Mizushima N,Komatsu M. Autophagy: renovation of cells and tissues[J]. Cell,2011,147(4): 728-41. doi: 10.1016/j.cell.2011.10.026
[7] Oral O, Akkoc Y, Bayraktar O, et al. Physiological and pathological significance of the molecular cross-talk between autophagy and apoptosis[J]. Histol Histopathol, 2016, 31(5): 479-98. [7] Oral O,Akkoc Y,Bayraktar O,et al. Physiological and pathological significance of the molecular cross-talk between autophagy and apoptosis[J]. Histol Histopathol,2016,31(5): 479-98. http://cn.bing.com/academic/profile?id=2293413684&encoded=0&v=paper_preview&mkt=zh-cn
[8] KuballaP, Nolte WM, Castoreno AB, et al. Autophagy and the immnune system[J]. Anna Revlmmunol, 2012, 30: 611-46. [8] KuballaP,Nolte WM,Castoreno AB,et al. Autophagy and the immnune system[J]. Anna Revlmmunol,2012,30: 611-46.
[9] Villanueva Paz M, Cotán D, Garrido-Maraver J, et al. Targetingautophagyand mitophagy for mitochondrial diseases treatment[J]. Expert Opin Ther Targets, 2016, 20(4): 487-500. [9] Villanueva Paz M,Cotán D,Garrido-Maraver J,et al. Targeting autophagy and mitophagy for mitochondrial diseases treatment[J]. Expert Opin Ther Targets,2016,20(4): 487-500. doi: 10.1517/14728222.2016.1101068
[10] Wang H, Gao N, Li Z, et al. AutophagyAlleviates Melamine- Induced Cell Death in PC12 Cells Via Decreasing ROS Level[J]. Mol Neurobiol, 2016, 53(3): 1718-29. [10] Wang H,Gao N,Li Z,et al. AutophagyAlleviates Melamine-Induced Cell Death in PC12 Cells Via Decreasing ROS Level[J].Mol Neurobiol,2016,53(3): 1718-29. doi: 10.1007/s12035-014-9073-2
[11] Fésüs L,Demény MA,Petrovski G. Autophagy shapes inflammation[J]. Antioxid Redox Signal,2011,14(11): 2233-43. doi: 10.1089/ars.2010.3485
[11] Fésüs L, Demény MA, Petrovski G. Autophagy shapes inflammation[J]. Antioxid Redox Signal, 2011, 14(11): 2233-43. [12] 杜芸, 李迎娟, 吴家宁, 等. 自噬基因Beclin1在细针穿刺乳腺 病变中的表达及其与Bcl-2和p53的相关性[J]. 肿瘤防治研究, 2013, 40(5): 459-62. [Du Y, Li YJ, Wu JN, et al. Expression of Beclin1 in fine needle aspiration breast lesions and its relationship with Bcl-2 and p53[J]. Zhong Liu Fang Zhi Yan Jiu, 2013, 40(5): 459-62.] [12] 杜芸,李迎娟,吴家宁,等. 自噬基因Beclin1在细针穿刺乳腺病变中的表达及其与Bcl-2和p53的相关性[J]. 肿瘤防治研究,2013,40(5): 459-62. http://www.zlfzyj.com/CN/abstract/abstract4262.shtml Du Y,Li YJ,Wu JN,et al. Expression of Beclin1 in fine needle aspiration breast lesions and its relationship with Bcl-2 and p53[J]. Zhong Liu Fang Zhi Yan Jiu,2013,40(5): 459-62. http://www.zlfzyj.com/CN/abstract/abstract4262.shtml
[13] Li Z, Chen B, Wu Y, et al. Genetic and epigenetic silencing of the beclin 1 gene in sporadic breast tumors[J]. BMC Cancer, 2010, 10: 98. [13] Li Z,Chen B,Wu Y,et al. Genetic and epigenetic silencing of the beclin 1 gene in sporadic breast tumors[J]. BMC Cancer,2010,10: 98. doi: 10.1186/1471-2407-10-98
[14] Ahn CH,Jeong EG,Lee JW,et al. Expression of beclin-1,an autophagy-related protein,in gastric and colorectal cancers[J].APMIS,2007,115(12): 1344-9. doi: 10.1111/apm.2007.115.issue-12
[14] Ahn CH, Jeong EG, Lee JW, et al. Expression of beclin-1, an autophagy-related protein, in gastric and colorectal cancers[J]. APMIS, 2007, 115(12): 1344-9. [15] Schnekenburger M,Grandjenette C,Ghelfi J,et al. Sustained exposure to the DNA demethylating agent,2’-deoxy-5-azacytidine,leads to apoptotic cell death in chronic myeloid leukemia by promoting differentiation,senescence,and autophagy[J]. Biochem Pharmacol,2011,81(3): 364-78. doi: 10.1016/j.bcp.2010.10.013
[15] Schnekenburger M, Grandjenette C, Ghelfi J, et al. Sustained exposure to the DNA demethylating agent, 2’-deoxy-5-azacytidine, leads to apoptotic cell death in chronic myeloid leukemia by promoting differentiation, senescence, and autophagy[J]. Biochem Pharmacol, 2011, 81(3): 364-78. [16] 赵洪萍,万安,周颖,等. 自噬在宫颈癌中的研究进展[J].国际妇产科学杂志,2015,42(2): 154-7. http://www.cnki.com.cn/Article/CJFDTOTAL-GWVC201502009.htm Zhao HP,Wan A,Zhou Y,et al. The progress of autophagy involved in cervical cancer[J]. Guo Ji Fu Chan Ke Xue Za Zhi,2015,42(2): 154-7. http://www.cnki.com.cn/Article/CJFDTOTAL-GWVC201502009.htm
[16] 赵洪萍, 万安, 周颖, 等. 自噬在宫颈癌中的研究进展[J].国际妇 产科学杂志, 2015, 42(2): 154-7. [Zhao HP, Wan A, Zhou Y, et al. The progress of autophagy involved in cervical cancer[J]. Guo Ji Fu Chan Ke Xue Za Zhi, 2015, 42(2): 154-7.] [17] 熊海燕.自噬性死亡在结肠癌化疗中的作用及其机制探讨[D].上海: 第二军医大学,2009. Xiong HY. The role of autophagic cell death in colon cancer cell chemotherapy[D]. Shanghai: Di Er Jun Yi Da Xue,2009.
[17] 熊海燕.自噬性死亡在结肠癌化疗中的作用及其机制探讨[D]. 上海: 第二军医大学, 2009. [Xiong HY. The role of autophagic cell death in colon cancer cell chemotherapy[D]. Shanghai: Di Er Jun Yi Da Xue, 2009.]